Brind.

On August 29, 2025, it was reported that Steven Quay is CEO of Atossa Therapeutics, Mark Smith is CEO of NioCorp, and the Elk Creek Project is located in Nebraska.

4 reports, 2 independent Updated Aug 29
Gone quiet Reached 2 outlets in its first 24 hours
Reports
4
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

On August 29, 2025, it was reported that Steven Quay is CEO of Atossa Therapeutics, Mark Smith is CEO of NioCorp, and the Elk Creek Project is located in Nebraska.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. New corporate structure and project location facts established for Atossa Therapeutics, NioCorp, and Elk Creek Project.1 source
  2. PSI selected as CRO for Atossa's dose-ranging study.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ACCESS NewswireNioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV ORLANDO, FL / ACCESS Newswire / August 29, 2025 / RedChip Companies will air intervie
  • PR NewswireAtossa Therapeutics CEO to Discuss Clinical Progress and Upcoming Milestones at 27th Annual H.C. Wainwright Global Investment Conference Dr. Steven Quay, Chairman and Chief Executive Officer to parti
  • PR NewswireAtossa Therapeutics Selects PSI as Contract Research Organization for Pivotal Dose-Ranging Study of (Z)-Endoxifen in Metastatic Breast Cancer Monotherapy Phase 2 study designed with FDA input; IND ex
  • ACCESS NewswireAtossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV ORLANDO, FL / ACCESS Newswire / August 1, 2025 / RedChip Companies wil